Patents by Inventor Mathias Pawlak

Mathias Pawlak has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240108689
    Abstract: The subject matter disclosed herein is generally directed to pathogenic Th1 cells whose phenotype is dependent on IL-23R signaling. Th1 cell specific therapeutic targets and gene programs are disclosed herein. In particular, inhibition of CD160 reduces Th1 cell pathogenicity.
    Type: Application
    Filed: January 21, 2022
    Publication date: April 4, 2024
    Inventors: Vijay K. Kuchroo, Ramnik Xavier, Mathias Pawlak, David DeTomaso, Nir Yosef